ÂÜÀòÂÒÂ×

Avery Wilson is a seasoned professional in regulatory affairs, currently serving as Manager of Regulatory Strategy at Sarepta Therapeutics since November 2022. In this role, Avery participates in regulatory strategic discussions and oversees the execution of regulatory activities across clinical trials and product registrations. Previous experience includes managing regulatory submissions and strategy for oncology products at AstraZeneca, where responsibilities encompassed submission delivery planning and mentoring team members. Earlier positions include roles at Novotech, where Avery ensured compliance and readiness for TMF audits, and Ashfield, focusing on customer care and sales operations. Education includes a Master of Science in Healthcare Policy and Regulatory Leadership from the University of Denver and a Bachelor of Science in Public Affairs Management from Indiana University Bloomington.